Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 7,252 | 566 | 392 | 1,503 | 208,383 |
| Gross Profit | 7,252 | 566 | 392 | 1,503 | 208,383 |
| Operating Expenses | 49,691 | 62,451 | 59,673 | 57,051 | 84,174 |
| Operating Income | -42,439 | -61,885 | -59,281 | -55,548 | 124,209 |
| Other Income | 25,025 | 35,452 | 6,942 | 1,379 | -46 |
| Pre-tax Income | -17,414 | -26,433 | -52,339 | -54,169 | 124,163 |
| Income Tax | N/A | N/A | N/A | N/A | 1,329 |
| Net Income Continuous | -17,414 | -26,433 | -52,339 | -54,169 | 122,835 |
| Net Income | $-17,414 | $-26,433 | $-52,339 | $-54,169 | $122,835 |
| EPS Basic Total Ops | -0.23 | -0.37 | -0.73 | -0.77 | 1.78 |
| EPS Basic Continuous Ops | -0.24 | -0.37 | -0.74 | -0.77 | 1.82 |
| EPS Diluted Total Ops | -0.23 | -0.37 | -0.73 | -0.77 | 1.76 |
| EPS Diluted Continuous Ops | -0.24 | -0.37 | -0.74 | -0.77 | 1.80 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.37 | -0.74 | -0.77 | 1.76 |
| EBITDA(a) | $-42,166 | $-61,272 | $-58,713 | $-54,167 | $124,446 |